1. Home
  2. HSDT vs KXIN Comparison

HSDT vs KXIN Comparison

Compare HSDT & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • KXIN
  • Stock Information
  • Founded
  • HSDT 2014
  • KXIN 2015
  • Country
  • HSDT United States
  • KXIN China
  • Employees
  • HSDT N/A
  • KXIN N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • HSDT Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • HSDT Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • HSDT 2.9M
  • KXIN 2.8M
  • IPO Year
  • HSDT N/A
  • KXIN N/A
  • Fundamental
  • Price
  • HSDT $0.54
  • KXIN $1.28
  • Analyst Decision
  • HSDT Buy
  • KXIN
  • Analyst Count
  • HSDT 2
  • KXIN 0
  • Target Price
  • HSDT $24.00
  • KXIN N/A
  • AVG Volume (30 Days)
  • HSDT 241.1K
  • KXIN 266.9K
  • Earning Date
  • HSDT 03-27-2025
  • KXIN 01-01-0001
  • Dividend Yield
  • HSDT N/A
  • KXIN N/A
  • EPS Growth
  • HSDT N/A
  • KXIN N/A
  • EPS
  • HSDT N/A
  • KXIN N/A
  • Revenue
  • HSDT $502,000.00
  • KXIN $12,679,000.00
  • Revenue This Year
  • HSDT N/A
  • KXIN N/A
  • Revenue Next Year
  • HSDT $8.97
  • KXIN N/A
  • P/E Ratio
  • HSDT N/A
  • KXIN N/A
  • Revenue Growth
  • HSDT N/A
  • KXIN N/A
  • 52 Week Low
  • HSDT $0.37
  • KXIN $1.20
  • 52 Week High
  • HSDT $7.19
  • KXIN $29.52
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 43.07
  • KXIN 39.34
  • Support Level
  • HSDT $0.50
  • KXIN $1.21
  • Resistance Level
  • HSDT $0.60
  • KXIN $1.44
  • Average True Range (ATR)
  • HSDT 0.06
  • KXIN 0.09
  • MACD
  • HSDT -0.01
  • KXIN 0.01
  • Stochastic Oscillator
  • HSDT 15.87
  • KXIN 29.17

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: